中聯重科發佈自研碳纖維複合材料新技術
格隆匯11月29日丨據證券時報,11月26日,在中聯重科新能源產品及碳纖維複合材料新技術發佈會上,我國首款國產化碳纖維臂架泵車亮相。中聯重科自主研發了“碳纖維復材-高強金屬混合結構技術”。該設計-計算-製造-試驗成套技術的研發成功,意味着我國工程機械實現了碳纖維複合材料從原材料、製造裝備,到設計計算方法、製造工藝的全鏈條自主化,大幅降低了工程機械領域碳纖維複合材料主承力結構件的價格成本,助力這類以碳纖維爲核心的新型結構商用落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.